 |
| Drug Delivery Technologies |
The design of medication delivery systems must take patient compliance into account, which is what is causing drug delivery to advance and innovate. The global market for improved medication delivery technologies is predicted to reach $227 billion by 2020, according to a report by US-based market research firm BCC Research. Various medication delivery methods
Given that so many
market players have a robust portfolio for the technology, targeted delivery
held the greatest market share of more than 23.0% in 2021. The ideal location
of action is provided through targeted delivery, which also helps keep
medications away from areas where they can become hazardous. The higher
bioavailability that these systems offer
The size of the global Drug Delivery Technologies Market was estimated at USD 34.70 billion in 2021 and is anticipated to increase from USD 39.33 billion in 2022 to USD 71.75 billion by 2029, at a projected CAGR of 9.0%.
Despite being one of
the most exciting and quickly expanding markets, the global market for improved
drug delivery technologies is expected to reach $227 billion by 2020. Table 1
lists the EDDS that are presently on the market or being developed for
commercial use. Compared to conventional delivery systems, this innovative
method of medication administration and delivery offers a number of benefits,
including precise and targeted dose distribution.
In this situation, the transdermal Drug Delivery Technologies Market, which is a painless, non-invasive drug delivery mechanism, is preferred over other traditional distribution routes. Here, a skin-sticker patch or another transdermal technique or device is used to deliver the medication in a discrete dosage form to the systemic circulation by penetrating through the skin layers.
The transdermal drug
delivery system a painless, non-invasive medication administration method, is
favored in this case over other conventional distribution channels. In this
case, the drug is administered to the systemic circulation by penetrating
through the layers of skin using a skin-sticker patch or another transdermal
approach or device.
In
this instance, the transdermal Drug Delivery Technologies Market, a painless,
non-invasive pharmaceutical administration approach, is preferred over other
traditional distribution systems. In this instance, the medicine is delivered
to the systemic circulation via permeating through the layers of skin using a
skin-sticker patch or another transdermal technique or device.
The COVID-19 pandemic
had a beneficial impact on the nasal drug delivery systems industry since many
people wanted to finish their home drug therapy for chronic respiratory
illnesses. As a result, more individuals utilized inhalers at home than at
clinics or hospitals. Nowadays, nasal inhalers are used increasingly regularly
to treat illnesses like asthma, migraines, and other mental illnesses.
0 Comments